Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
Phase 2
Completed
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Drug: placebo plus Prevacid
- First Posted Date
- 2008-03-19
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Ranjan Dohil
- Target Recruit Count
- 32
- Registration Number
- NCT00638456
- Locations
- 🇺🇸
Rady Children's Hospital, San Diego, San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath